To establish the best measure for determining magnesium overload, we measured ionized and total magnesium in serum and mononuclear blood cells and total magnesium in erythrocytes in blood of 23 hemodialysis patients, known for their disturbed magnesium homeostasis. When comparing the mean magnesium values obtained in the patient population with those of a control population, all of these magnesium markers, including the biologically active fractions, were significantly (P <0.05) increased. Because serum total magnesium was not increased in all dialysis patients studied, the population was divided into two groups, according to total serum magnesium >1.0 mmol/L or less than that. Results in these two populations showed that ionized serum magnesium and ionized magnesium in mononuclear blood cells might give a better indication about the magnesium status of the tested patients than the currently used total serum magnesium data. However, neither of the two markers, especially ionized serum magnesium, was able to discriminate fully between normal magnesium homeostasis and magnesium excess. We therefore conclude that the two ionized magnesium markers offer minimal advantage for this discrimination, and that the total magnesium concentration in serum remains the measurement of choice.
In trying to obtain information about the magnesium (Mg) status of a patient, clinician and clinical chemists are generally confined to measuring the total magnesium concentration in serum (tMg s ) 3 However, around 1990, ion-selective electrodes for determining ionized Mg in blood became available [1] . In our laboratory we evaluated one of these electrodes and subsequently established reference values with it [2, 3] . This method measures the biologically active Mg fraction, which possibly gives more reliable information on the functional Mg status. However, because serum Mg represents Ͻ1% of total body Mg, several techniques for measuring intracellular Mg in many kinds of tissues and cells have been published [4 -6] .
In 1991, Ng et al. described a method for measuring ionized Mg in human lymphocytes, using a Mg-sensitive fluorescent probe in combination with spectrophotometry [7] . We tested several aspects of this so-called multiplecell detection method (MCDM) and compared the results by this system with the intracellular ionized Mg concentrations measured by flow cytometry, a so-called singlecell detection method (SCDM). We concluded (see Appendix) that Mg concentrations measured by both techniques are comparable, but we prefer MCDM because it is more easily accessible and less expensive, even though flow cytometry has the advantage of detecting single cells.
In the present study we tried to assess which Mg marker in blood might best indicate deviations from the "normal" condition in healthy subjects. Therefore, we measured extracellular Mg and intracellular Mg, both ionized concentrations and total concentrations, in blood of 23 hemodialysis patients. Known for their disturbed Mg homeostasis [5] , these patients represent a model for hypermagnesemia in this study. We then compared the intracellular and extracellular Mg fractions in this specific patient population with the commonly used tMg s value and with Mg values measured in blood from healthy volunteers.
Materials and Methods subjects
Venous blood used for measurements of ionized and total Mg in serum was drawn into plain, nonsiliconized 4.5-mL tubes. Blood for determining total Mg concentrations in mononuclear blood cells (MBC; tMg MBC ) and in erythrocytes (RBC; tMg RBC ) was collected in 10-mL heparincontaining tubes, and blood for determining ionized Mg in MBC (iMg 2ϩ MBC ) was drawn into 10-mL tubes containing 0.8 g of polystyrene granules. All tubes used were Vacutainer Tubes (Becton Dickinson).
Reference values for iMg 2ϩ MBC were obtained by drawing blood from 40 healthy laboratory workers (16 men, 24 women; median age 36 years, range 21-54 years). Reference values for the other Mg markers had already been established during previous Mg studies in our laboratory [3] .
The chronic hemodialysis patients (16 men, 7 women; median age 60 years, range 26 -85 years) participating in the study were in a stable condition, hydrated to normal on clinical grounds, and had been treated with hemodialysis for a median of 15 months (range 3-188 months). Underlying renal diseases were chronic glomerulonephritis (n ϭ 14), chronic tubular interstitial nephritis (n ϭ 8), and unknown (n ϭ 1). All patients were treated 2 or 3 times a week with a dialysis solution containing Mg at 0.5 mmol/L (Gambro BV); no MgCO 3 was used as a phosphate-binding agent. Blood was obtained just before treatment was started. All procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 1983.
chemicals
Fluorescent probes [Mag-indo-1/acetoxymethyl ester (AM) and Mag-fura-2/AM] were obtained from Molecular Probes Europe. The ionophore 4-Br-A23187 and nigericin were obtained from Sigma Chemical Co., EDTA and ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA) from Boehringer Mannheim GmbH. Other chemicals, all of analytical-reagent grade, were purchased from E. Merck BV.
procedures
Measurement of total and ionized Mg in serum. After clotting (45 min) and centrifugation (10 min, 1500g), serum was separated from the cells and stored in completely filled rubber-sealed air-tight tubes at Ϫ20°C, for no more than 4 weeks. After thawing, the pH was only slightly increased, so the ionized Mg fraction did not change significantly. tMg s was measured by atomic absorption spectroscopy (PE2100; Perkin-Elmer), the ionized serum Mg (iMg 2ϩ s ) by a Mg ion-selective electrode installed in the Microlyte 6 ion analyzer (KONE Instruments).
Isolation of MBC and loading with fluorescent probe. MBC and RBC used for the determination of the total and ionized intracellular Mg concentration were isolated from heparinized and defibrinated blood, respectively, as described previously [8] . After counting and differentiating the cells, we dissolved in 1. We used two different fluorescent probes, loading the cells with Mag-indo-1/AM or Mag-fura-2/AM at final concentrations of 10.9 and 9.4 mol/L, respectively, by a modification of the method of Raju et al. [9] . The cell suspension also contained Pluronic R 20% (in dimethyl sulfoxide) and probenecid at final concentrations of 0.3 g/L and 1.0 mmol/L, respectively. The main difference between the two fluorescent probes is their difference in emission and excitation behavior. Mag-indo-1 is a dualemission probe, whereas Mag-fura-2 is a dual-excitation probe. The advantage of the latter is its greater increasing ratio from minimum to maximum Mg concentration, which theoretically allows better precision of the Mg measurement. So, after comparing flow-cytometric intracellular Mg measurements with multiple-cell detection (see Appendix), we used the MCDM with Mag-fura-2 for further measurements.
Measurement of total intracellular Mg concentration.
The total Mg concentration in MBC and RBC was measured as described previously [8] . The number of isolated cells was counted with a Bayer-H3 system, the protein concentration of the MBC lysate was measured photometrically after treatment with Coomassie Brilliant Blue (Microprot; Oxford Labware), and Mg was measured by atomic absorption spectrophotometry, as above. The intracellular Mg concentration of MBC was expressed as mol/g protein; that of RBC, as fmol/cell.
Measurement of intracellular ionized Mg concentration.
The intracellular ionized Mg fraction was determined by using the equation established by Grynkiewicz et al. [10] :
with K d the dissociation constant of the probe/Mg complex, R the excitation or emission ratio at the current intracellular Mg concentration, R min the excitation or emission ratio at minimal intracellular Mg concentration, R max the ratio at maximal intracellular Mg concentration, S f the fluorescence intensity of the highest wavelength at (Fig. 1) . The iMg 2ϩ s concentration of this patient group differed from normal also (P ϭ 0.038), but not as significantly as the intracellular Mg fractions (for tMg MBC , P ϭ 0.003; for tMg RBC , P Ͻ0.001; and for iMg 2ϩ MBC , P ϭ 0.003). In hemodialysis group 2 (tMg s Ͼ1.0 mmol/L), all Mg markers except tMg MBC were increased in comparison with the healthy population.
Discussion comparison of mag-indo-1 and mag-fura-2
The measurements performed with Mag-indo-1 and Magfura-2 in both the healthy volunteers and the hemodialysis patients lead us to conclude that these fluorescent probes measure comparable intracellular Mg concentrations. This conclusion is supported by preceding studies with two calcium probes, Indo-1 and Fura-2, which also detected no difference [11, 12] . For the present study, therefore, we pooled the iMg 2ϩ MBC concentrations measured with both probes.
mg in hemodialysis patients and healthy volunteers
The human body contains ϳ1 mol of Mg, Ͻ1% of which is present in blood. It is important to determine, therefore, which of the proposed Mg markers gives the best information about the Mg status of the body. Must clinical chemists continue reporting tMg s ; should iMg 2ϩ s become the measurement of choice; or is none of the current measurable serum markers appropriate? If none of these, might intracellular Mg markers give proper information about hyper-and hypomagnesemia (possibly depending on the type of disease)? In attempts to answer this question, several studies about measurement and correlations between Mg in serum, RBC, MBC, and tissues (e.g., skeletal muscle, heart, and bone) have been performed. Several reviews on this subject also have been published [13] [14] [15] . Although the collective results are still contradictory, to date tMg MBC seems to give the most appropriate estimate of intracellular Mg. In this study we focused on measurements in serum and blood cells, and evaluated the value of two new Mg markers (iMg 2ϩ s and iMg 2ϩ MBC ) for establishing whether Mg excess was present. We measured these two Mg markers and the total Mg concentration in serum, MBC, and RBC in blood of chronic hemodialysis patients. Because the kidneys play a major role in Mg homeostasis [16] , chronic hemodialysis patients are often hypermagnesemic, the extent depending on the Mg concentration in the dialysis solution applied. Because of their Mg overload, these patients form a suitable model for this study [5, 17] .
In comparison with the mean Mg values measured in the healthy population, all Mg markers in patients, including the biologically active fractions, were greater, but not all ratios of the Mg markers between the two groups were equal (Table 1) . Only the increases in the two serum markers were exactly the same (1.27) . This means that in this patient population, iMg 2ϩ s , the biologically active fraction, is not kept at a more constant value than tMg s , and the two fluctuate in the same manner. Moreover, even if an active mechanism such as transmembrane Mg channels in MBC might exist to keep the ionized Mg s concentrations were greater in the patient population, whereas the concentration of ionized Mg in lymphocytes was comparable in both groups. Kaupke et al. [20] measured the intracellular ionized fraction in platelets of 9 patients with end-stage renal disease and an increased tMg s , who were treated with hemodialysis (dialysate containing 0.5 mmol/L Mg). Surprisingly, the Mg concentration measured in these patients was considerably lower than in the normal group. This finding was explained as probably resulting from various clinical conditions to which patients with end-stage renal disease are particularly prone. The discrepancies between our results and those of Kisters et al. [19] and Kaupke et al. [20] show that the final word on this subject has not yet been spoken.
Because not all dialysis patients studied had increased serum total Mg, we looked at dividing the population into two groups (Table 2 ), according to their tMg s concentration (cutoff value 1.0 mmol/L). Assuming that all of the patients, including those in group 1 (tMg s Յ1.0 mmol/L), had a Mg excess, we could conclude that iMg 2ϩ s and the three intracellular Mg markers give more reliable information about the Mg status of the tested patients than does the currently used total serum Mg data (Fig. 1) . On the other hand, despite the difference between the mean values of iMg 2ϩ s , which was significant, the measured concentrations overlapped considerably, the mean iMg Of the three intracellular markers, iMg 2ϩ MBC and tMg RBC deviated more from the reference value than did tMg MBC . Even in patient group 2 (tMg s Ͼ1.0 mmol/L), tMg MBC did not differ significantly from that seen in the control population, probably as a result of the high CV for this Mg assay (14%) [8] . tMg RBC values in this specific patient population result from several influences. In uremic patients RBC have a decreased life span, which results in increased erythropoiesis. Because young RBC contain much more Mg than older cells, hemodialysis patients can be expected to have an increased tMg RBC [21] [22] [23] . Moreover, the increased serum Mg concentration during erythropoiesis can enhance this effect. In our study, tMg RBC correlated with extracellular Mg (tMg s and iMg 2ϩ s ). On the other hand, an increased rate of Na/Mg antiport in hemodialysis patients, which leads only to Mg efflux out of RBC, partially compensates for the intracellular increase [24] . In our opinion, all these influences combine to make RBC Mg an unsuitable measure of Mg overload in hemodialysis patients.
The remaining intracellular Mg marker, iMg 2ϩ MBC , is not able to discriminate fully between normal Mg homeostasis and Mg excess (Fig. 1) . Although this measurement showed the largest increase in the hemodialysis population (Table 1) , and its mean concentration in patient group 1 was significantly increased ( Before a final decision can be made on which magnesium fraction should be determined to monitor the true magnesium status of the body, it is necessary to investigate which method is preferable for determining ionized intracellular Mg. Here we discuss which method is preferable for determination of ionized magnesium in lymphocytes (iMg 2ϩ L ), flow cytometry or fluorometry. Some studies have already demonstrated determination of iMg 2ϩ L in a cell suspension with use of a magnesium-sensitive fluorescent probe and a fluorometer [6, 19, [25] [26] [27] . In this multiple-cell detection method (MCDM) setup, the result for iMg 2ϩ L is strongly affected by the use of an extracellular probe that allows the analyte to leak out of the cells into the surrounding buffer. Avoiding this interference requires a single-cell detection method (SCDM), such as confocal laser scanning microscopy or flow cytometry. Because the flow cytometer is now a common tool in clinical chemistry, we chose to use a flow cytometer equipped with a UV laser for this comparison study.
Using a SCDM to determine the iMg 2ϩ L concentration has other advantages: Because iMg 2ϩ L is determined in each individual cell, we can study the distribution of iMg 2ϩ L in a sample [28] ; moreover, a certain population of cells can be selected, which means that the purity of the initial sample (isolation of lymphocytes from other MBC) is less important.
In this study, we wanted to determine the preferred method for measuring iMg 2ϩ L by comparing the SCDM and the MCDM (flow cytometry vs fluorometry), using lymphocytes from 21 healthy volunteers and 14 hemodialysis patients. The healthy volunteers, 11 women and 10 men, were ages 21-60 years (median 36 years). The hemodialysis patients, 6 women and 8 men, ages 26 -75 years (median 60 years), were dialyzed two or three times a week for 4 h with dialysate containing magnesium at 0.50 mmol/L. As above, the study was performed according to the World Medical Association Declaration of Helsinki.
study setup
Isolation of and treatment of lymphocytes. As described above in the main report, venous blood was obtained in Vacutainer Tubes containing heparin or polystyrene granules to obtain 4.5 mL of heparinized blood or 20 mL of defibrinated blood, respectively. The lymphocytes in the heparinized blood were used for SCDM determinations of iMg 2ϩ L ; the lymphocytes harvested from defibrinated blood were used for MCDM determinations of iMg 2ϩ L . Lymphocytes were isolated from whole blood as described by Huijgen et al. [8] . Some of the harvested cells were counted and differentiated, and the remaining cells were dissolved in buffer, as described above in Materials and Methods.
For determining iMg 2ϩ L with a fluorescent probe, we loaded the cells with Mag-indo-1/AM by a modification of the method of Raju et al. [9] : Mag-indo-1/AM was added at a final concentration of 10.9 mol/L to the cell suspension in buffer that also contained Pluronic and probenecid (concentrations as stated in Materials and Methods). This suspension was incubated for 30 -40 min at 37°C with gentle shaking. A portion of unloaded lymphocytes were reserved for measurement of autofluorescence by the MCDM.
After the loading, the lymphocytes were centrifuged at 150g for 12 min and the pellet was maintained at room temperature for another 30 min to allow the Mag-indo-1/AM to de-esterify. For cytosolic ion measurement, the cells were washed once and resuspended at 0.5 ϫ 10 6 lymphocytes per milliliter in the same buffer but without fetal calf serum Using the SCDM, we could exclude dead cells from the final analysis by staining the cells with propidium iodide (Sigma; final concentration 12.5 mol/L). Forward scatter (FSC), sideway scatter (SSC), and the propidium iodide fluorescence were detected after excitation at 488 nm. The scatter intensities were detected with BP485/10 filters, and the fluorescence of propidium iodide was detected with a DF630/22 bandpass filter. In the FSC-SSC pattern, all lymphocytes were selected, whereas the fluorescence of propidium iodide allowed exclusion of the dead cells. Only the fluorescence of the living cells was used to calculate R. By MCDM, labeled lymphocytes were measured at 37°C with a dual-excitation and emission fluorometer (Aminco Bowman Series 2 luminescence spectrometer). Excitation was at 347 nm; emission was monitored in 0.5-s intervals at 467 nm (free Mag-indo-1) and 428 nm (bound Mag-indo-1). To eliminate any fluorescence from probe leaking out of the cells, EGTA/EDTA (Sigma; final concentration 1.25 mmol/L) in Tris-HCl, 0.1 mol/L, was added to bind the extracellular iMg 2ϩ . Because the autofluorescence detected never exceeded 1%, we calculated R directly from the fluorescence intensities (Eq. A1). Data were analyzed with the standard software on the SLM-Aminco.
Measuring iMg
We used R, obtained from the fluorescence intensities determined by both methods, to calculate the iMg 2ϩ L concentration as demonstrated before by Grynkiewicz et al. [10] 2ϩ can diffuse freely through the membrane, leaving the membrane more or less intact. The success of the permeation can be checked by using the SCDM: The shape and form of the cells can be studied with the FSC-SSC pattern, and the fluorescence intensity of Mag-indo-1 is studied only inside the cell. The following products for permeation have been tested: digitonin [29, 30] , octylglucoside [31] , saponin [32] , FACS Lyse [31, 33] , and 4Br-A23187 [7, 34] . When digitonin, octylglucoside, and saponin are used, the FSC-SSC pattern shifts towards the very small particles, indicating that the cell membrane is completely destroyed; with FACS Lyse and 4Br-A23187, the FSC-SSC pattern (and presumably the cell membrane) remains intact. However, the fluorescent properties of Mag-indo-1 change in the presence of FACS Lyse (which first permeates the cells and then fixates [31, 33] ), whereas 4Br-A23187 does not alter these fluorescent properties. These results clearly demonstrate the usefulness of 4Br-A23187 as an ionophore for magnesium in lymphocytes, so we used 4Br-A23187 to permeate the cells for measurement of K d .
To obtain a minimal iMg L concentrations: After EGTA/ EDTA and 4Br-A23187 were added, small amounts of 0.5 mol/L MgCl 2 were added and R was measured. The free Mg 2ϩ concentrations were calculated with the program CHELATOR [35] . We then performed linear regression over the (9) 
L , and, as was shown in Eq. 1 for iMg 2ϩ MBC , determined K d as the regression coefficient of the fit. The goodness of the fit is expressed by R 2 . In general we reported the mean Ϯ SE of a group. Statistical analyses were performed with the Mann-Whitney U-test and the statistical package SPSS (version 6.1.3) or the one-sample t-test when appropriate.
results and discussion
The K d of Mag-indo-1 with magnesium was 2.9 mmol/L (n ϭ 5, R 2 Ͼ0.95) in the SCDM and 2.1 mmol/L (n ϭ 12, R 2 Ͼ0.88) in the MCDM-different results but of the same magnitude, and in the same range as reported in the literature: 2.8 mmol/L [36] and 2.03 mmol/L [37] . For both methods, within-day and overall CVs were determined for samples from two different healthy persons (Table A1 ). The CV within-day was slightly lower for the MCDM than the SCDM, whereas the CV overall was slightly lower for the SCDM. Niemela et al. [18] reported a CV overall of 11.0% for Mag-fura-2 in platelets, comparable with that for the SCDM. Others have found smaller values for CV overall for a MCDM and Mag-fura-2: 6.5% in lymphocytes [7, 25] , 3.6% in platelets [29] .
Effect of high extracellular iMg
2ϩ concentrations on iMg 2ϩ L . We investigated the effect of increased extracellular iMg 2ϩ on the intracellular iMg 2ϩ L by using the SCDM. R (Eq. A1) was studied at a normal extracellular iMg 2ϩ concentration, 0.42 mmol/L (R normal ), and a high concentration, 4.20 mmol/L (R high ). Under these conditions, the difference in R, defined as [(R normal Ϫ R high )/R normal ] ϫ 100%, was respectively Ϫ4.4%, Ϫ1.3%, and Ϫ0.4% after incubation for 100, 150, and 200 min at this high concentration of extracellular magnesium. All these values fall within the error margin of R; thus, within 200 min or ϳ3.3 h, no effect of the high extracellular iMg 2ϩ concentration was noted. Because both R min and R max were unaffected by the increase in extracellular iMg 2ϩ , even after a long exposure to such concentrations, R can be recorded instead of iMg 2ϩ L , obviating the time-consuming determinations of R min and R max .
Difference between methods for iMg 2ϩ L in healthy volunteers.
For both SCDM and MCDM, iMg 2ϩ L was determined in blood collected at the same venipuncture from 21 healthy volunteers. After isolation, the cells were counted and the leukocytes were differentiated from the mixture of MBC in the samples. The mean lymphocyte concentration, relative to the total concentration of MBC, was 90% by the MCDM and 94% by the SCDM.
After staining and washing the cells, the fluorescent experiments were performed. In the MCDM, R decreased 12% after EGTA/EDTA was added to achieve a magnesium-and calcium-free extracellular buffer. This decrease demonstrates that fluorescent probe is present in the extracellular environment. In the SCDM, however, R was unaffected by the addition of the chelators EGTA/EDTA.
The mean iMg 2ϩ L (ϮSE) in the healthy volunteers was 0.27 Ϯ 0.01 mmol/L by the SCDM and 0.24 Ϯ 0.01 Clinical Chemistry 44, No. 3, 1998 mmol/L by the MCDM (Table A2) Fig. A1 [38] . The mean log difference was 0.06 (95% confidence interval, Ϫ0.01 to 0.13). Because the confidence interval includes 0, we conclude there is no bias between the two methods. Indeed, a one-sample t-test performed on the logarithmic difference in iMg 2ϩ L gave P ϭ 0.10 (not significant). Table A3 .
Both iMg 2ϩ s and tMg s were significantly greater in the patients (n ϭ 14) than in the volunteers (n ϭ 21), as others have also found [20, 39] . Kisters et al. [19] found no significantly increased tMg s or iMg 2ϩ s in patients with renal insufficiency. In contrast, Markell et al. [39] found lower iMg 2ϩ s in hemodialysis patients. This difference in serum magnesium concentrations is probably caused by differences in the magnesium concentration in the dialysate, 0.50 mmol/L (here and [19] ) vs 0.375 mmol/L [39] . In the present study, the magnesium concentration in the dialysate (0.50 mmol/L) was lower than the concentration of iMg 2ϩ s (0.68 mmol/L). The mean iMg 2ϩ L was slightly higher in the patients than in the volunteers (Table A3) , but not significantly, probably because of the size of the two groups studied. Kisters et al. [19] , also determining iMg 2ϩ L in renal insufficiency patients and healthy volunteers, found the same results: The iMg 2ϩ L was greater in the renal insufficiency group, but the difference was not significant.
The distribution in iMg 2ϩ L (determined by using the distribution in R) for each hemodialysis patient ranged from 0.35 to 0.55 measuring units (1 unit is not equal to 1 mmol/L); for the healthy volunteers, the range was 0.32 to 0.56 measuring units. Table A4 compares the mean iMg L in a population of lymphocytes can be studied [28] ; and (c) the SCDM can select a small population of cells, indicating that the purity of the sample is not important. On the other hand, the MCDM is easy to handle, relatively cheap, and available in almost every laboratory, whereas the SCDM required has to be equipped with an expensive UV laser. To determine whether the theoretical advantages of the SCDM could be mirrored in a practical situation, we used the flow cytometer and the fluorometer to study the iMg 2ϩ L in healthy volunteers and hemodialysis patients. The dissociation constant between the fluorescent probe and magnesium, K d , is needed for calculating the iMg 2ϩ L from the fluorescence intensity of the fluorescent probe. As demonstrated before [40] , the K d recorded in a buffer differs from that recorded in cells; the K d also differs for each apparatus used. Therefore, the K d had to be determined for each apparatus as well as inside the lymphocytes. For both the SCDM and the MCDM, the K d has to be determined by disrupting the cell membrane in such a way that Mg 2ϩ can diffuse freely through the membrane while the fluorescent probe remains inside the cell. In the SCDM, the disruption of the cells can be studied in the FSC-SSC pattern.
A. Effect of extracellular probe leaking out of the cells. Theoretically, the R that is measured after the addition of EGTA/EDTA is smaller than the true R: the fluorescence intensity of free Mag-indo-1 is overestimated because it is the sum of both extracellular and intracellular free probe, whereas the fluorescence intensity of bound Mag-indo-1 is the true fluorescence intensity, arising only from intracellular Mag-indo-1. Eq. A1 easily shows that the measured R is smaller than the true R. Because the other factors needed to calculate iMg 2ϩ L are unaffected, the iMg 2ϩ now measured is smaller than the true iMg 2ϩ (Eq. 1). Therefore, the iMg L by both methods increases, we calculated the logarithmic difference and the logarithmic sum. As discussed before, the 95% confidence interval for the logarithmic difference included 0, and a one-sample t-test demonstrated no bias between the two methods [38] . Therefore, the effect of the extracellular probe on the iMg 2ϩ L is negligible and the MCDM can be used without much difficulty.
B. Effect of the distribution of the magnesium concentration in a population of lymphocytes. Although the mean iMg 2ϩ L is the same for healthy volunteers and hemodialysis patients (Table A3 ), the distribution of iMg 2ϩ L within one sample might be different between these two groups. Examining the width of the distribution in the ratio R should give an indication about the width in distribution in iMg 2ϩ L . However, the distribution of R was the same for both hemodialysis patients and healthy volunteers, 0.2 measuring units. Therefore, the distribution of iMg In conclusion, the SCDM has the advantages of being insensitive to the interference of extracellular probe and to the purity of the sample and offers the possibility of studying the distribution of the intracellular ionized magnesium concentrations in a sample. The MCDM has the advantages of being easily accessible, available in most laboratories, and less expensive then the SCDM with a UV laser. In this study, however, we found no significant difference in the mean iMg 2ϩ L determined by both methods. Nor was a difference found in the width of the distribution of iMg 2ϩ L in hemodialysis patients and healthy volunteers. Moreover, the reproducibility in iMg 2ϩ L in both methods is similar, indicating that the purity of the sample as used here does not affect the reproducibility. Therefore, all of the theoretical advantages expected with use of the SCDM were of no effect in this practical situation. On the basis of these results and keeping financial considerations in mind, we conclude that the MCDM, the fluorometer, is the preferred method for determining iMg 2ϩ L . Ng et al. [25] 0.15 5 13 MCDM, Mag-fura-2 Ng et al. [7] 0.15 20 27 MCDM, Mag-fura-2 Willems et al. [26] 0.78 13 6 MCDM, Mag-fura-2 Lemmers et al. [27] 0.57 7 21 MCDM, Mag-fura-2 Kisters et al. [19] 2 
